Cargando…

Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?

Severe Acute Respiratory Distress Syndrome caused by a novel human coronavirus SARS-CoV-2 named COVID-19 and declared as a pandemic. This paper reviews the possibility of repurposing angiotensin type 1 receptor (AT1R) antagonists and vitamin D to treat COVID-19. ACE2 protein found on the cell membra...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rafiullah, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Southern Society for Clinical Investigation. Published by Elsevier Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362851/ https://www.ncbi.nlm.nih.gov/pubmed/32736832 http://dx.doi.org/10.1016/j.amjms.2020.07.018

Ejemplares similares

Can Vitamin D Deficiency Increase the Susceptibility to COVID-19?
por: Maha, Quratulain, et al.
Publicado: (2021)

Vitamin D may prevent COVID-19 induced pregnancy complication
por: Al-Kaleel, Ali, et al.
Publicado: (2022)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
por: Camilleri, Eleonora, et al.
Publicado: (2021)

Vitamin D in infectious complications in critically ill patients with or without COVID-19
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Vitamin D and Lung Outcomes in Elderly COVID-19 Patients
por: Sulli, Alberto, et al.
Publicado: (2021)

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
por: Dörr, Jan, et al.
Publicado: (2013)

Vitamin D can reduce severity in COVID-19 through regulation of PD-L1
por: Aygun, Hatice
Publicado: (2022)

Anticoagulation Quality and Complications of using Vitamin K Antagonists in the Cardiac Surgery Outpatient Clinic
por: da Costa, Mário Augusto Cray, et al.
Publicado: (2016)

Modified BLUE protocol ultrasonography can diagnose thrombotic complications of COVID‐19 with normal lung ultrasound
por: Zaalouk, Tamer Mohamed, et al.
Publicado: (2021)

Platelet Dysfunction in Thrombosis Patients Treated with Vitamin K Antagonists and Recurrent Bleeding
por: van der Meijden, Paola E. J., et al.
Publicado: (2013)

Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
por: Fakhoury, Hana. M. A., et al.
Publicado: (2021)

Role of vitamin D in treating COVID-19-associated coagulopathy: problems and perspectives
por: Sengupta, Tanusree, et al.
Publicado: (2021)

Vitamin D can prevent COVID-19 infection-induced multiple organ damage
por: Aygun, Hatice
Publicado: (2020)

Vitamin D Status: Can It Affect the Risk of Infection and the Severity of COVID-19 Symptoms?
por: Paiz, Nicole, et al.
Publicado: (2021)

Vitamin D status can affect COVID-19 outcomes also in pediatric population
por: Miraglia del Giudice, Michele, et al.
Publicado: (2022)

Vitamin D and COVID-19
por: Trovas, George, et al.
Publicado: (2020)

Vitamin D and COVID-19
Publicado: (2020)

Vitamin D and COVID-19
por: Thacher, Tom D.
Publicado: (2021)

Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes
por: Nawaz, Shaik Sarfaraz, et al.
Publicado: (2022)

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists
por: van Heteren, D. Max, et al.
Publicado: (2022)

Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19
por: Zeidan, Nancy M. S., et al.
Publicado: (2022)

Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
por: Qu, Changbo, et al.
Publicado: (2021)

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1
por: Khazan, Negar, et al.
Publicado: (2023)

The effect of a combined oral calcium and vitamin D supplement for treating mild to moderate vitamin D deficiency in postmenopausal women
por: Golombick, Terry, et al.
Publicado: (2008)

Risk of overanticoagulation during acute kidney injury in patients treated with vitamin K antagonists
por: Süfling, Luisa, et al.
Publicado: (2021)

Can the Combination of Rehabilitation and Vitamin D Supplementation Improve Fibromyalgia Symptoms at All Ages?
por: Scaturro, Dalila, et al.
Publicado: (2022)

Can screening for low vitamin D levels prevent bone health complications in paediatric oncology patients?
por: Naeije, Leonie, et al.
Publicado: (2021)

Vitamin D and Vitamin D binding protein: the inseparable duo in COVID-19
por: Speeckaert, M. M., et al.
Publicado: (2021)

Vitamine D et COVID-19
Publicado: (2020)

Vitamine D et Covid-19
por: Piraux, Arthur
Publicado: (2021)

Relation of vitamin D to COVID-19
por: Saxena, Priyanka, et al.
Publicado: (2022)

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists
por: Visser, Chantal, et al.
Publicado: (2022)

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists
por: Visser, Chantal, et al.
Publicado: (2021)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
por: Cheng, Richard Z.
Publicado: (2020)

Serum vitamin D and diabetic foot complications
por: Greenhagen, Robert M., et al.
Publicado: (2019)

Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
por: Kishore, E, et al.
Publicado: (2023)

Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?
por: Slominski, Andrzej T., et al.
Publicado: (2020)

Interleukin 1-β, interleukin-1 receptor antagonist and vitamin D levels in children with atopic dermatitis
por: Machura, Edyta, et al.
Publicado: (2018)

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
por: Faniyi, Aduragbemi A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qfje9ud87nnu05n2c7c3u8eqd